# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

> **NCT00017368** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 42 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** sargramostim
- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** etoposide phosphate
- **DRUG:** ifosfamide
- **DRUG:** isotretinoin
- **DRUG:** melphalan
- **DRUG:** thiotepa
- **DRUG:** vincristine sulfate
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00017368
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2005-09
- **Final completion:** 2012-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017368, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00017368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*